FeesSafety
Pluang+

AI leaders call for slower development, sparking market crash amid broader economic fears

Market News
15 Sep 2026
Seeking Alpha
View Source
Bearish
AI leaders call for slower development, sparking market crash amid broader economic fears

Anthropic CEO Dario Amodei urged a slowdown in AI development, a stance supported by OpenAI's Sam Altman and Elon Musk, leading to a sharp market drop on Monday. Despite the market's negative reaction, experts believe this pause is more about tech giants buying time to address competitive pressures from China rather than a true halt in AI progress. Alongside concerns over AI, ongoing geopolitical tensions and fears of interest rate hikes are also weighing heavily on markets this September. Investors are advised to view the current market fear as a potential buying opportunity.

The pace of AI development is under scrutiny, with calls for a slowdown amid competitive and geopolitical pressures. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 21:21 WIB: out of 150 priced US tech stocks, 50 rose and 96 fell. Notable gainers include Transocean Ltd (RIG) at USD 5.65 (+3.67%), Nokia Corp (NOK) at USD 9.99 (+3.52%), and Hewlett Packard Enterprise Co (HPE) at USD 57.32 (+3.45%).

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
1 hour ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
2 hours ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
2 hours ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
2 hours ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App